Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer

Abstract Background Many previous studies have demonstrated that minor-frequency pretreatment T790M mutation (preT790M) could be detected by ultrasensitive methods in a considerable number of treatment-naïve, epidermal growth factor receptor (EGFR)-mutated, non-small cell lung cancer (NSCLC) cases....

Full description

Bibliographic Details
Main Authors: Yoshiya Matsumoto, Tomoya Kawaguchi, Masaru Watanabe, Shun-ichi Isa, Masahiko Ando, Akihiro Tamiya, Akihito Kubo, Chiyoe Kitagawa, Naoki Yoshimoto, Yasuhiro Koh
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Cancer
Subjects:
Non-small cell lung cancer
EGFR mutation
Pretreatment T790M
Resection
Recurrence-free survival
Online Access:https://doi.org/10.1186/s12885-022-09869-7

Internet

https://doi.org/10.1186/s12885-022-09869-7

Similar Items